# Ashvattha Therapeutics

**Canonical:** https://apis.io/providers/ashvattha-therapeutics/  
**Website:** https://avttx.com/  
**APIs profiled:** 0

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company developing a new class of precision nanomedicines built on hydroxyl dendrimer therapeutics (HDTs), a platform exclusively licensed from Johns Hopkins University. Hydroxyl dendrimers traverse tissue barriers such as the blood-retinal and blood-brain barrier and are selectively taken up by activated cells in regions of inflammation, allowing known small-molecule drugs to be delivered intracellularly to diseased tissue with sustained effect and reduced off-target exposure. The company is advancing programs across ophthalmology, neurology, and inflammatory disease, led by migaldendranib (MGB), a first-in-class subcutaneously administered nanomedicine in Phase 2 development for diabetic macular edema and neovascular age-related macular degeneration, plus hydroxyl dendrimer PET imaging tracers such as [18F]OP-801. Founded by Jeffrey L. Cleland, Kannan Rangaramanujam, and Sujatha Kannan. Ashvattha publishes no public developer program, API, or machine-readable interface.

## Kin Score — 6.7 / 100 (minimal)

Scored 2026-08-25 under rubric 0.14.0. Trend: flat (-0.7 from 7.4).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Ashvattha Therapeutics Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Nanomedicine, Drug Development, Clinical Trials, Ophthalmology, Neurology, Health

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/ashvattha-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.